Literature DB >> 10492731

Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.

S Danet1, T Brousseau, F Richard, P Amouyel, C Berr.   

Abstract

STUDY
OBJECTIVE: Age, family history of dementia and the epsilon 4 allele of the apolipoprotein E gene have been associated with Alzheimer's disease (AD). Considering the strength of APOE-epsilon 4 as a genetic risk factor for AD, this factor might explain a large part of the association between AD and a family history of dementia. Therefore, in the general population, a higher frequency of dementia should be observed among parents of probands with at least one epsilon 4 allele than in parents of probands without this allele. DESIGN, SETTING, AND PARTICIPANTS: The study investigated a sample of 1153 volunteers between 59 and 71 years old, genotyped for the APOE gene, all participating in the EVA study. Dementia in their parents was determined using a self reported questionnaire. MAIN
RESULTS: The frequency of dementia in 2164 parents was examined and it was found that 245 were demented. The percentage of demented parents was 13.0% in the subgroup of parents of subjects having one or two epsilon 4 alleles and 10.8% in the other subgroup. The relative risk of dementia among parents according to the APOE-epsilon 4 status of probands, was calculated using a Cox model adjusted for the educational level of parents and their history of stroke: RR = 1.21 (95% CI 0.90, 1.63).
CONCLUSION: This lack of association supports the observation that in the general population, APOE-epsilon 4 cannot explain a large part of family history of dementia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492731      PMCID: PMC1756916          DOI: 10.1136/jech.53.7.393

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  30 in total

1.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

2.  The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease.

Authors:  R Mayeux; Y Stern; R Ottman; T K Tatemichi; M X Tang; G Maestre; C Ngai; B Tycko; H Ginsberg
Journal:  Ann Neurol       Date:  1993-11       Impact factor: 10.422

3.  Association of apolipoprotein E E4 with vascular dementia.

Authors:  G B Frisoni; A Bianchetti; S Govoni; M Trabucchi; L Calabresi; G Franceschini
Journal:  JAMA       Date:  1994-05-04       Impact factor: 56.272

4.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study.

Authors:  A Hofman; A Ott; M M Breteler; M L Bots; A J Slooter; F van Harskamp; C N van Duijn; C Van Broeckhoven; D E Grobbee
Journal:  Lancet       Date:  1997-01-18       Impact factor: 79.321

5.  Apolipoprotein E polymorphism and Alzheimer's disease.

Authors:  J Poirier; J Davignon; D Bouthillier; S Kogan; P Bertrand; S Gauthier
Journal:  Lancet       Date:  1993-09-18       Impact factor: 79.321

6.  Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease.

Authors:  T Brousseau; S Legrain; C Berr; V Gourlet; O Vidal; P Amouyel
Journal:  Neurology       Date:  1994-02       Impact factor: 9.910

7.  The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group.

Authors:  A Hofman; W A Rocca; C Brayne; M M Breteler; M Clarke; B Cooper; J R Copeland; J F Dartigues; A da Silva Droux; O Hagnell
Journal:  Int J Epidemiol       Date:  1991-09       Impact factor: 7.196

8.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Authors:  A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

9.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

Authors:  M C Chartier-Harlin; M Parfitt; S Legrain; J Pérez-Tur; T Brousseau; A Evans; C Berr; O Vidal; P Roques; V Gourlet
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.